Q2 Solutions operates one of the world's largest and most respected bioanalytical and ADME laboratory networks. From our global locations, we serve many of the largest pharmaceutical, specialty pharmaceutical and biotechnology companies in North America, South America, Europe, and Asia. Our highly trained and experienced scientists utilize a range of leading-edge technology, automation, and state-of-the-art techniques.
From high-throughput ADME screening services and human clearance predictions to support drug metabolism and pharmacokinetics studies to drug-drug interaction testing and metabolite profiling to support clinical safety, the Q2 Solutions global network offers solutions to support every phase of drug discovery and development.
How we can support your needs:
In addition. Q2 Solutions can provide bundled services for discovery and regulatory-phase packages to enable decision-making at each step of the development process.
Specifica, a Q2 Solutions company, is applying its proven platform for antibody discovery to generate recombinant monoclonal antibody reagents. Our in vitro display approach eliminates the need for...
ImmunXperts, a Q2 Solutions company, provides functional insights into immune-mediated adverse events. We provide in silico and in vitro methods, using T-cell activation and proliferation as a...
If you’re looking for solutions to analytical challenges, you’ve come to the right place. Our highly trained scientists partner with you to provide a well-planned strategy, no matter where you are in...